2014,AAMI,"ANSI/AAMI/ISO 10993-13-2010/(R)2014 - Biological evaluation of medical devices-Part 13: Identification and quantification of degradation products from polymeric devices"
2001,AAMI,"ANSI/AAMI/ISO 10993-14:2001/(R)2011 - Biological evaluation of medical devices-Part 14: Identification and quantification of degradation products from ceramics"
2006,AAMI,"ANSI/AAMI/ISO 10993-2-2006/(R)2014 - Biological evaluation of medical devices-Part 2: Animal welfare requirements"
2014,AAMI,"ANSI/AAMI/ISO 10993-3:2014 - Biological evaluation of medical devices-Part 3: Tests for genotoxicity, carcinogenicity, and reproductive toxicity"
2009,AAMI,"ANSI/AAMI/ISO 10993-9:2009/(R)2014 - Biological evaluation of medical devices, Part 9: Framework for identification and quantification of potential degradation products"
2006,AAMI,"AAMI/ISO TIR10993-19:2006 [HISTORICAL] Biological evaluation of medical devices—Part 19: Physico-chemical, morphological, and topographical characterization of materials"
2016,AAMI,"ANSI/AAMI/ISO 22442-2:2016 - Medical devices utilizing animal tissues and their derivatives-Part 2: Controls on sourcing, collection and handling."
2014,AAMI,"ANSI/AAMI/ISO TIR37137:2014 - Cardiovascular biological evaluation of medical devices-Guidance for absorbable implants"
2006,AAMI,"ANSI/AAMI BE83:2006/(R)2011 - Biological evaluation of medical devices-Part 18: Chemical characterization of materials"
2009,AAMI,"ANSI/AAMI/ISO 10993-5:2009/(R)2014 - Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity"
2016,AAMI,"ANSI/AAMI/ISO 10993-6:2016 - Biological evaluation of medical devices-Part 6: Tests for local effects after implantation"
2012,AAMI,"ANSI/AAMI/ISO 10993-12:2012 - Biological evaluation of medical devices-Part 12: Sample preparation and reference materials"
2002,AAMI,"ANSI/AAMI/ISO 10993-17:2002/(R)2012 - Biological evaluation of medical devices-Part 17: Establishment of allowable limits for leachable substances"
2007,AAMI,"ANSI/AAMI/ISO 22442-3:2007/(R)2016 - Medical devices utilizing animal tissues and their derivatives-Part 3: Validation of the elimination and/or inactivation of viruses and transimissible spongiform encephalopathy (TSE) agents"
2011,AAMI,"AAMI/ISO TIR22442-4:2011/(R)2016 - Medical devices utilizing animal tissues and their derivatives-Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes"
2010,AAMI,"ANSI/AAMI/ISO 10993-10:2010/(R)2014 - Biological evaluation of medical devices-Part 10: Tests for irritation and skin sensitization"
2012,AAMI,"ANSI/AAMI/ISO 13022:2012 - Medical products containing viable human cells-Application of risk management and requirements for processing practices"
2011,AAMI,"ANSI/AAMI/ISO 14155:2011 - Clinical investigation of medical devices for human subjects."
2006,AAMI,"ANSI/AAMI/ISO TIR10993-20:2006 - Biological evaluation of medical devices  -  Part 20: Principles and methods for immunotoxicology testing of medical devices"
2019,AAMI,"ANSI/AAMI/ISO 10993-15:2019 Biological evaluation of medical devices-Part 15: Identification and quantification of degradation products from metals and alloys"
2017,AAMI,"ANSI/AAMI/ISO 10993-16:2017"
2017,AAMI,"ANSI/AAMI/ISO 10993-11:2017, Biological evaluation of medical devices-Part 11: Tests for systemic toxicity"
2017,AAMI,"ANSI/AAMI/ISO 10993-4:2017, Biological evaluation of medical devices-Part 4: Selection of tests for interactions with blood"